CASC-674
N/A
Report date: 2022/01/12 18:08:53
Base Information
Drug NameCASC-674
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdimab LLCCascadian Therapeutics IncSeagen Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesCascadian Therapeutics Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A